If you are using a program through TrimRx that utilizes Compounded Semaglutide or Compounded Tirzepatide, these are almost exclusively once-weekly injections
To reduce the selection bias and observed confounding between the two groups, inverse probability of treatment weighting (IPTW) [21] was derived by conducting a regularized logistic regression with elastic net penalty on the semaglutide group vs DPP4i group with the following variables: age, race and ethnicity, index year, payer type, CCI, DCSI, glucose-lowering medications, baseline HbA1c level, baseline BMI and obesity diagnosis, health care utilization at baseline, comorbidities, and other medications at baseline
Insurance plans might cover part or the entire cost
Patient-specific factors include age (older adults have more fragile blood vessels and thinner skin), genetic predisposition to easy bruising, nutritional status, and underlying medical conditions affecting coagulation or vascular integrity